ArticleFrontiers in immunology2023

Immune response to SARS-CoV-2 mRNA vaccination in multiple sclerosis patients after rituximab treatment interruption.

Remigius Gröning et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.